Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

13.24
-0.2700-2.00%
Pre-market: 13.250.0082+0.06%08:49 EDT
Volume:1.89M
Turnover:25.08M
Market Cap:1.83B
PE:-3.67
High:13.49
Open:13.41
Low:13.12
Close:13.51
52wk High:15.40
52wk Low:4.40
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.94
T/O Rate:1.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:21.61
PE(LYR):-4.30

Loading ...

What's Going On With Enveric Biosciences Stock On Friday?

Benzinga
·
Apr 25

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications

Reuters
·
Apr 25

BRIEF-Compass Pathways Says FDA Granted NDA Rolling Review Request & Awarded Commissioner's National Priority Voucher

Reuters
·
Apr 25

Psychedelic Pharma Stocks Are Riding High. Past Cannabis Returns Are a Reality Check. -- Barrons.com

Dow Jones
·
Apr 24

Stock Track | COMPASS Pathways Soars 5.03% Intraday on FDA Fast-Tracking Psychedelic Drug Research and Regulatory Progress

Stock Track
·
Apr 24

BUZZ-U.S. STOCKS ON THE MOVE-Zoom, Compass Pathways,  X-Energy

Reuters
·
Apr 24

Compass Pathways Says Rolling Review Request Granted by FDA

MT Newswires Live
·
Apr 24

Compass Pathways announces FDA granted NDA rolling review request

TIPRANKS
·
Apr 24

Compass Pathways Plc - Cnpv Program Provides Shortened 1-2 Month Review Time After Nda Filing

THOMSON REUTERS
·
Apr 24

Compass Pathways Plc - Awarded Cnpv for Comp360 for Treatment-Resistant Depression

THOMSON REUTERS
·
Apr 24

Compass Pathways Announces FDA Granted Nda Rolling Review Request and Awarded Commissioner's National Priority Voucher

THOMSON REUTERS
·
Apr 24

BUZZ-Compass Pathways rises after FDA fast-tracks psychedelic drug research

Reuters
·
Apr 24

Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%

THOMSON REUTERS
·
Apr 24

Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%

THOMSON REUTERS
·
Apr 24

Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order

THOMSON REUTERS
·
Apr 24

Compass Pathways Initiated at Buy by B. Riley Securities

Dow Jones
·
Apr 24

B. Riley Initiates COMPASS Pathways at Buy With $17 Price Target

MT Newswires Live
·
Apr 24

Stock Track | Compass Pathways Soars 7.21% in Pre-market After B. Riley Initiates Coverage with Buy Rating and $17 Target

Stock Track
·
Apr 24

Compass Pathways initiated with a Buy at B. Riley

TIPRANKS
·
Apr 24

Compass Pathways Plc : B. Riley Initiates Coverage With Buy Rating; Target Price $17

THOMSON REUTERS
·
Apr 24